Uludağ H - Search Results

1

Impact of tether length on bone mineral affinity of protein-bisphosphonate conjugates.

Gittens SA, Kitov PI, Matyas JR, Löbenberg R, Uludağ H. Gittens SA, et al. Among authors: uludag h. Pharm Res. 2004 Apr;21(4):608-16. doi: 10.1023/b:pham.0000022407.05163.01. Pharm Res. 2004. PMID: 15139517

2

Bisphosphonate conjugation to proteins as a means to impart bone affinity.

Uludag H, Kousinioris N, Gao T, Kantoci D. Uludag H, et al. Biotechnol Prog. 2000 Mar-Apr;16(2):258-67. doi: 10.1021/bp990154m. Biotechnol Prog. 2000. PMID: 10753453

3

Bone affinity of a bisphosphonate-conjugated protein in vivo.

Uludag H, Gao T, Wohl GR, Kantoci D, Zernicke RF. Uludag H, et al. Biotechnol Prog. 2000 Nov-Dec;16(6):1115-8. doi: 10.1021/bp000066y. Biotechnol Prog. 2000. PMID: 11101342

4

Growth factor delivery for bone tissue engineering.

Gittens SA, Uludag H. Gittens SA, et al. Among authors: uludag h. J Drug Target. 2001;9(6):407-29. doi: 10.3109/10611860108998776. J Drug Target. 2001. PMID: 11822814 Review.

5

Targeting systemically administered proteins to bone by bisphosphonate conjugation.

Uludag H, Yang J. Uludag H, et al. Biotechnol Prog. 2002 May-Jun;18(3):604-11. doi: 10.1021/bp0200447. Biotechnol Prog. 2002. PMID: 12052079

6

Bisphosphonates as a foundation of drug delivery to bone.

Uludag H. Uludag H. Curr Pharm Des. 2002;8(21):1929-44. doi: 10.2174/1381612023393585. Curr Pharm Des. 2002. PMID: 12171528 Review.

7

Imparting bone affinity to glycoproteins through the conjugation of bisphosphonates.

Gittens SA, Matyas JR, Zernicke RF, Uludağ H. Gittens SA, et al. Among authors: uludag h. Pharm Res. 2003 Jul;20(7):978-87. doi: 10.1023/a:1024445903306. Pharm Res. 2003. PMID: 12880282

8

Systemic bone formation with weekly PTH administration in ovariectomized rats.

Gittens SA, Wohl GR, Zernicke RF, Matyas JR, Morley P, Uludag H. Gittens SA, et al. Among authors: uludag h. J Pharm Pharm Sci. 2004 Jan 30;7(1):27-37. J Pharm Pharm Sci. 2004. PMID: 15144732 Free article.

9

Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates.

Gittens SA, Bagnall K, Matyas JR, Löbenberg R, Uludag H. Gittens SA, et al. Among authors: uludag h. J Control Release. 2004 Aug 11;98(2):255-68. doi: 10.1016/j.jconrel.2004.05.001. J Control Release. 2004. PMID: 15262417

10

A di(bisphosphonic acid) for protein coupling and targeting to bone.

Bansal G, Gittens SA, Uludağ H. Bansal G, et al. Among authors: uludag h. J Pharm Sci. 2004 Nov;93(11):2788-99. doi: 10.1002/jps.20186. J Pharm Sci. 2004. PMID: 15368528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters